How are Stuhlprobe and Wechseljahre related?

The question of how stool samples relate to menopause touches on an emerging field: the gut microbiome–hormone axis. During menopause, declining estrogen levels can alter gut microbial composition, and conversely, certain gut bacteria (the 'estrobolome') can metabolize and recycle estrogens. A stool sample (microbiome analysis) could theoretically provide insights into microbial diversity and potential dysbiosis relevant to menopausal health. However, the clinical evidence for a direct, actionable benefit is still weak. Most commercial tests overstate their predictive power: they measure bacterial abundances but lack standardized reference ranges for menopause, and prospective trials showing that targeted interventions (e.g., probiotics) significantly alleviate menopausal symptoms are limited. Diet, medications, and lifestyle influence the microbiome more strongly than hormonal status alone. A stool test may serve as a complementary snapshot, but it does not replace medical hormone diagnostics. Caution is warranted against exaggerated marketing claims; the evidence is currently 'mixed' to 'unclear'.